EIF2S2 as a prognostic marker and therapeutic target in glioblastoma: insights into its role and downstream mechanisms
Abstract Glioblastoma (GBM) the most common and most aggressive primary brain tumor has a five-year survival rate of less than 5%. The onset of GBM is very complicated and has always been the focus of researchers. This study analyzed data from 637 GBM and 20 normal tissues from The Cancer Genome Atl...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-04-01
|
| Series: | Cancer Cell International |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12935-025-03762-6 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849765397165768704 |
|---|---|
| author | Bo Fan Qing Pan Xiaokai Yuan Wei Du Zhongjie Yan |
| author_facet | Bo Fan Qing Pan Xiaokai Yuan Wei Du Zhongjie Yan |
| author_sort | Bo Fan |
| collection | DOAJ |
| description | Abstract Glioblastoma (GBM) the most common and most aggressive primary brain tumor has a five-year survival rate of less than 5%. The onset of GBM is very complicated and has always been the focus of researchers. This study analyzed data from 637 GBM and 20 normal tissues from The Cancer Genome Atlas (TCGA), and patients were categorized into high and low EIF2S2 expression groups. The Overall survival and disease-free survival of GBM patients in low expression of EIF2S2 group were significantly higher than those in high expression of EIF2S2 group (p < 0.001), and the expression level of EIF2S2 was significantly correlated with tumor grade (p < 0.001) and tumor recurrence (p < 0.001). The study designed three different short hairpin RNA (shRNA) sequence vectors, identifying shEIF2S2-1 as the most effective. This vector significantly reduced EIF2S2 expression, cell proliferation, and migration while increasing apoptosis in SHG-44 and U251 cells (p < 0.01). By detecting SHG-44 cells infected with shEIF2S2 vector and shCtrl with human whole gene expression chip, we identified WNT5A that is a downstream target gene of EIF2S2. Interfering with WNT5A and overexpressing EIF2S2 in SHG-44 and U251 cells revealed that EIF2S2 regulates WNT5A expression. This regulation led to an increased apoptosis rate (p < 0.05) and a significant reduction in cell migration (p < 0.05) in both the EIF2S2 overexpression and shWNT5A interference groups, confirming that WNT5A is a downstream regulatory target of EIF2S2. This study revealed the key role of EIF2S2 in GBM and its potential molecular mechanism. |
| format | Article |
| id | doaj-art-406f778b5401425b901b21825d88f682 |
| institution | DOAJ |
| issn | 1475-2867 |
| language | English |
| publishDate | 2025-04-01 |
| publisher | BMC |
| record_format | Article |
| series | Cancer Cell International |
| spelling | doaj-art-406f778b5401425b901b21825d88f6822025-08-20T03:04:53ZengBMCCancer Cell International1475-28672025-04-0125111710.1186/s12935-025-03762-6EIF2S2 as a prognostic marker and therapeutic target in glioblastoma: insights into its role and downstream mechanismsBo Fan0Qing Pan1Xiaokai Yuan2Wei Du3Zhongjie Yan4Department of Neurosurgery, The Second Hospital of Hebei Medical UniversityDepartment of Hemodialysis, The Second Hospital of Hebei Medical UniversityDepartment of Rehabilitation Medicine, The Second Hospital of Hebei Medical UniversityDepartment of Neurosurgery, The Second Hospital of Hebei Medical UniversityDepartment of Neurosurgery, The Second Hospital of Hebei Medical UniversityAbstract Glioblastoma (GBM) the most common and most aggressive primary brain tumor has a five-year survival rate of less than 5%. The onset of GBM is very complicated and has always been the focus of researchers. This study analyzed data from 637 GBM and 20 normal tissues from The Cancer Genome Atlas (TCGA), and patients were categorized into high and low EIF2S2 expression groups. The Overall survival and disease-free survival of GBM patients in low expression of EIF2S2 group were significantly higher than those in high expression of EIF2S2 group (p < 0.001), and the expression level of EIF2S2 was significantly correlated with tumor grade (p < 0.001) and tumor recurrence (p < 0.001). The study designed three different short hairpin RNA (shRNA) sequence vectors, identifying shEIF2S2-1 as the most effective. This vector significantly reduced EIF2S2 expression, cell proliferation, and migration while increasing apoptosis in SHG-44 and U251 cells (p < 0.01). By detecting SHG-44 cells infected with shEIF2S2 vector and shCtrl with human whole gene expression chip, we identified WNT5A that is a downstream target gene of EIF2S2. Interfering with WNT5A and overexpressing EIF2S2 in SHG-44 and U251 cells revealed that EIF2S2 regulates WNT5A expression. This regulation led to an increased apoptosis rate (p < 0.05) and a significant reduction in cell migration (p < 0.05) in both the EIF2S2 overexpression and shWNT5A interference groups, confirming that WNT5A is a downstream regulatory target of EIF2S2. This study revealed the key role of EIF2S2 in GBM and its potential molecular mechanism.https://doi.org/10.1186/s12935-025-03762-6GBMEIF2S2WNT5ASHG-44U251 |
| spellingShingle | Bo Fan Qing Pan Xiaokai Yuan Wei Du Zhongjie Yan EIF2S2 as a prognostic marker and therapeutic target in glioblastoma: insights into its role and downstream mechanisms Cancer Cell International GBM EIF2S2 WNT5A SHG-44 U251 |
| title | EIF2S2 as a prognostic marker and therapeutic target in glioblastoma: insights into its role and downstream mechanisms |
| title_full | EIF2S2 as a prognostic marker and therapeutic target in glioblastoma: insights into its role and downstream mechanisms |
| title_fullStr | EIF2S2 as a prognostic marker and therapeutic target in glioblastoma: insights into its role and downstream mechanisms |
| title_full_unstemmed | EIF2S2 as a prognostic marker and therapeutic target in glioblastoma: insights into its role and downstream mechanisms |
| title_short | EIF2S2 as a prognostic marker and therapeutic target in glioblastoma: insights into its role and downstream mechanisms |
| title_sort | eif2s2 as a prognostic marker and therapeutic target in glioblastoma insights into its role and downstream mechanisms |
| topic | GBM EIF2S2 WNT5A SHG-44 U251 |
| url | https://doi.org/10.1186/s12935-025-03762-6 |
| work_keys_str_mv | AT bofan eif2s2asaprognosticmarkerandtherapeutictargetinglioblastomainsightsintoitsroleanddownstreammechanisms AT qingpan eif2s2asaprognosticmarkerandtherapeutictargetinglioblastomainsightsintoitsroleanddownstreammechanisms AT xiaokaiyuan eif2s2asaprognosticmarkerandtherapeutictargetinglioblastomainsightsintoitsroleanddownstreammechanisms AT weidu eif2s2asaprognosticmarkerandtherapeutictargetinglioblastomainsightsintoitsroleanddownstreammechanisms AT zhongjieyan eif2s2asaprognosticmarkerandtherapeutictargetinglioblastomainsightsintoitsroleanddownstreammechanisms |